The endoscopy device market is anticipated to expand from US$ 30,457.18 million in 2022 to US$ 52,100.72 million by 2030, reflecting a compound annual growth rate (CAGR) of 6.9% during the period from 2022 to 2030.

This report outlines the current trends and key factors propelling market growth. The increase in market size is primarily linked to the rising preference for minimally invasive surgical procedures and the growing incidence of cancer, which significantly influences the demand for endoscopy devices. Furthermore, the integration of artificial intelligence (AI) in gastroenterology is expected to become a prominent trend in the market throughout the forecast period. Nevertheless, the potential risk of infections associated with endoscopic procedures poses a challenge to market expansion from 2022 to 2030.

The rising demand for minimally invasive surgical techniques is a major driver of market growth in the upcoming years.

There is a notable shift in medical practices and patient preferences towards minimally invasive surgical techniques. This trend is fueled by the desire to reduce the invasiveness of procedures, lower associated risks, and facilitate quicker recovery times. Endoscopy represents a minimally invasive surgical approach that requires only small incisions, leading to shorter recovery periods and enhanced visibility of internal body structures. Surgeons can utilize an endoscope to visualize and operate within the body without the need for large incisions. These minimally invasive methods typically involve smaller cuts and the use of specialized instruments and technologies to access various organs, resulting in reduced hospital stays and minimal scarring.

Patients benefit from less pain and a faster return to their normal activities. Surgeons are increasingly adopting these techniques due to their advantages, coupled with advancements in medical devices and surgical expertise. Consequently, healthcare facilities are investing in training their medical personnel and acquiring the necessary equipment to cater to the growing demand for minimally invasive endoscopic surgeries, thereby enhancing patient treatment options and overall healthcare experiences.

The incorporation of artificial intelligence is emerging as a significant trend in the endoscopy device market.

The utilization of artificial intelligence (AI) in gastrointestinal (GI) endoscopy is gaining considerable attention due to its potential to enhance the quality of endoscopic procedures at all levels. AI can significantly reduce or eliminate human errors, providing greater accuracy, consistency, and speed. One of the key benefits of AI is its ability to minimize inter-operator variability, compensating for the varying levels of experience among endoscopists. In November 2019, AI Medical Service Inc. received Breakthrough Device Designation from the US FDA for its AI programs that analyze endoscopic images to assist in the diagnosis of gastric cancer.

Over the last forty years, the incidence of esophageal adenocarcinoma (EAC) has surged, largely due to the rising rates of obesity. AI assistance has shown promising results in enhancing the detection and diagnosis of EAC, thereby reducing the mortality and morbidity associated with late-stage diagnoses of this cancer.

Recently, several AI-driven endoscopy products have gained global approval. For example, Ibex Medical Analytics introduced the first AI platform for cancer diagnosis, utilizing algorithms to analyze biopsy images, locate tumors, and assess their grade. This technology aids pathologists in accurately diagnosing gastric cancer. In June 2021, the US FDA granted Breakthrough Device Designation to Ibex's Galen platform, which streamlines the clinical review and regulatory approval process. Galen Gastric serves as an integrated diagnostic and quality control solution, assisting pathologists in identifying gastric cancer, dysplasia, H. pylori infections, and other critical clinical findings. Additionally, in April 2021, Medtronic plc received de novo clearance from the FDA for the GI Genius intelligent endoscopy module, a computer-aided detection (CADe) system that employs AI to highlight colon areas with visual characteristics indicative of various mucosal abnormalities.

As AI technology continues to advance, it promises to improve diagnostic accuracy, procedural efficiency, and patient-centered care within endoscopy systems. Therefore, the application of AI in gastroenterology is likely to become a significant trend in the global endoscopy device market in the near future.

Report Segmentation and Scope -

The "global endoscopy device market" is categorized based on product type, application, and end user. The product segment includes endoscopes, visualization systems, accessories, and other endoscopy devices. The endoscopes segment is further divided into flexible endoscopes, rigid endoscopes, robot-assisted endoscopes, and capsule endoscopes. The visualization systems segment encompasses wireless displays and monitors, light sources, video processors, endoscopic cameras, video recorders, video converters, carts, transmitters and receivers, camera heads, and other instruments. The other endoscopy devices segment includes both electronic and mechanical instruments. The accessories segment is subdivided into cleaning brushes, overtubes, surgical dissectors, light cables, fluid flushing devices, needle holders/forceps, mouthpieces, biopsy valves, and more. By application, the endoscopy device market is divided into gastroscopy, laparoscopy, arthroscopy, otoscopy, urology endoscopy, bronchoscopy, laryngoscopy, and other applications. The end user segment includes hospitals, ambulatory surgical centers, and others.

In terms of product, the endoscopes segment accounted for the largest share of the endoscopy device market in 2022. The visualization systems segment is projected to exhibit the highest CAGR from 2022 to 2030. These systems are crucial in endoscopic procedures as they provide high-quality images and videos. Components of visualization systems include wireless displays, monitors, light sources, video processors, endoscopic cameras, video recorders, video converters, carts, transmitters and receivers, camera heads, and other instruments. Companies like Boston Scientific Corporation and KARL STORZ SE & Co. KG are key providers of visualization systems in the endoscopy device market.

Regarding applications, the gastroscopy segment held the largest share of the endoscopy equipment market in 2022, while the laparoscopy segment is expected to achieve the highest CAGR from 2022 to 2030. Gastroscopy, or upper endoscopy, involves examining the upper gastrointestinal tract, including the esophagus, stomach, and duodenum, to diagnose conditions such as ulcers, tumors, inflammation, and gastroesophageal reflux disease (GERD). Endoscopy devices for gastroscopy are typically flexible endoscopes equipped with advanced imaging capabilities, including high-definition cameras and optical enhancements.

In terms of end users, hospitals represented the largest share of the endoscopy device market in 2022 and are expected to register the highest CAGR during 2022-2030. Hospitals encompass a wide range of medical facilities, from community hospitals to large academic medical centers, and are significant consumers of endoscopy devices. The demand for these devices in hospitals is driven by a high volume of patients, comprehensive care delivery, and advanced procedures. Hospitals are well-equipped to perform complex endoscopic procedures, including surgeries and specialized therapeutic interventions. Various endoscopic examinations, such as cystoscopies and ureteroscopy for kidney stones, are commonly conducted in hospital settings. Similarly, many ENT endoscopies are performed in both inpatient and outpatient hospital environments.

The report on the endoscopy device market references several key sources, including Globocan 2020, the International Trade Administration (ITA), Frontiers Public Health in 2022, and The National Center for Biotechnology Information (NCBI).